BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16909220)

  • 1. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.
    Hayashida Y; Yakushiji T; Awai K; Katahira K; Nakayama Y; Shimomura O; Kitajima M; Hirai T; Yamashita Y; Mizuta H
    Eur Radiol; 2006 Dec; 16(12):2637-43. PubMed ID: 16909220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience.
    Asmar K; Saade C; Salman R; Saab R; Khoury NJ; Abboud M; Tamim H; Makki M; Naffaa L
    Eur J Radiol; 2020 Mar; 124():108855. PubMed ID: 32018075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
    Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
    Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
    Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
    Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors.
    Degnan AJ; Chung CY; Shah AJ
    Clin Imaging; 2018; 47():9-13. PubMed ID: 28806574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.
    Oka K; Yakushiji T; Sato H; Hirai T; Yamashita Y; Mizuta H
    Skeletal Radiol; 2010 Feb; 39(2):141-6. PubMed ID: 19924412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging of brain tumors: a short temporal interval assessment.
    Li X; Qu JR; Luo JP; Li J; Zhang HK; Shao NN; Kwok K; Zhang SN; Li YL; Liu CC; Zee CS; Li HL
    J Magn Reson Imaging; 2014 Sep; 40(3):616-21. PubMed ID: 24925118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents.
    Alsharief AN; Martinez-Rios C; Hopyan S; Amirabadi A; Doria AS; Greer MC
    Pediatr Radiol; 2019 Aug; 49(9):1201-1208. PubMed ID: 31203404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration.
    Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA
    Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
    Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
    Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
    Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
    PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas.
    Holscher HC; Bloem JL; Nooy MA; Taminiau AH; Eulderink F; Hermans J
    AJR Am J Roentgenol; 1990 Apr; 154(4):763-9. PubMed ID: 2107673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions.
    Chiu FY; Jao JC; Chen CY; Liu GC; Jaw TS; Chiou YY; Hsu FO; Hsu JS
    J Comput Assist Tomogr; 2005; 29(2):176-80. PubMed ID: 15772533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.
    Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
    Eur J Radiol; 2019 Oct; 119():108635. PubMed ID: 31445487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma.
    Saito K; Araki Y; Park J; Metoki R; Katsuyama H; Nishio R; Kakizaki D; Moriyasu F; Tokuuye K
    J Magn Reson Imaging; 2010 Jul; 32(1):229-34. PubMed ID: 20578029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of b value on monitoring therapeutic response by diffusion-weighted imaging.
    Jiang ZX; Peng WJ; Li WT; Tang F; Liu SY; Qu XD; Wang JH; Lu HF
    World J Gastroenterol; 2008 Oct; 14(38):5893-9. PubMed ID: 18855990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conspicuity of Malignant Liver Tumors on Diffusion-Weighted Imaging With Short tau Inversion Recovery After Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid Administration.
    Iwanaga T; Fukukura Y; Saito T; Sasaki M; Kumagae Y; Takumi K; Hakamada H; Fujisaki T; Saigo Y; Yoshiura T
    J Magn Reson Imaging; 2019 Feb; 49(2):565-573. PubMed ID: 30102432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
    van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
    AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas.
    Dudeck O; Zeile M; Pink D; Pech M; Tunn PU; Reichardt P; Ludwig WD; Hamm B
    J Magn Reson Imaging; 2008 May; 27(5):1109-13. PubMed ID: 18425832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.